Entera Bio Ltd. — Director's Dealing 2022

Jan 24, 2022

SEC Form 3/A — Form 3/A

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: JAMAS SPIROS (Chief Executive Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.24	2031-01-04	Ordinary Shares, par value NIS 0.0000769 per share (1314218)		Direct

Footnotes

F1: This Form 3 amendment is being filled to correct the original Form 3 filed on January 20, 2022. The original Form 3 inadvertently marked the Reporting Person as a director of Entera Bio Ltd. The Reporting Person is only an officer of Entera Bio Ltd. as reflected herein.